Dopamine autoreceptor stimulation: clinical significance

Area of Science:

• Neuropharmacology
• Psychiatry
• Endocrinology

Background:

• Dopamine autoreceptors are present on several dopaminergic neuron systems, influencing dopamine synthesis and release.
• Evidence for autoreceptors on tuberoinfundibular dopamine neurons is limited.
• Recent studies have questioned the existence of autoreceptors on mesolimbic and nigrostriatal dopamine neurons.

Purpose of the Study:

• To review the evidence for dopamine autoreceptors across different neuronal pathways.
• To discuss the clinical effects of low-dose dopamine agonists.
• To present new findings on tuberoinfundibular dopamine autoreceptors and propose future research strategies.

Main Methods:

• Review of existing literature on dopamine autoreceptors and dopamine agonist effects.
• Analysis of clinical data on low-dose apomorphine, N-propylapomorphine, and bromocriptine.
• Presentation of new evidence regarding tuberoinfundibular dopamine neurons in humans.

Main Results:

• Low-dose dopamine agonists show potential antipsychotic effects and can ameliorate tardive dyskinesia and extrapyramidal symptoms.
• A subset of patients experienced depression after low-dose apomorphine administration.
• Evidence suggests a lack of dopamine autoreceptors on human tuberoinfundibular dopamine neurons.

Conclusions:

• Low-dose dopamine agonists have diverse clinical applications but require careful monitoring due to potential side effects.
• The role and even existence of dopamine autoreceptors in certain pathways remain subjects of ongoing research.
• Further studies are needed to fully elucidate the dopamine autoreceptor concept in humans.